ID   BCHi004-A
SY   HNDS0050-01 #D
DR   hPSCreg; BCHi004-A
DR   Wikidata; Q107113442
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient that is mosaic for a CDKL5 p.Asp135Gly mutation, but this cell line does not contain this mutation.
CC   Derived from sampling site: Skin; dermis. Cell type=Fibroblast.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_A7KG ! BCHi004-B
SX   Male
AG   26Y10M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 17-03-22; Version: 3
RX   PubMed=33714067; DOI=10.1016/j.scr.2021.102276;
RA   Chen P.-F., Chen T., Forman T.E., Swanson A.C., O'Kelly B., Dwyer S.A.,
RA   Buttermore E.D., Kleiman R., Carrington S.J.S., Lavery D.J.,
RA   Swanson L.C., Olson H.E., Sahin M.;
RT   "Generation and characterization of human induced pluripotent stem
RT   cells (iPSCs) from three male and three female patients with CDKL5
RT   deficiency disorder (CDD).";
RL   Stem Cell Res. 53:102276-102276(2021).